Invert Graphite Limited has released a press release.
Appendix 4C
Filed with ASX ·
On 6ix: 6ix.com/news/appendix-4c-60
6ix hasn’t read this filing yet.
Invert Graphite Limited on 6ix
Earlier from Invert Graphite
- Phase II clinical trial progress update
- Half Year Accounts
- Appendix 4C - December 2016 quarter
- Phase II Clinical Trial - First Patient In
- Collaboration and IP option agreement with Monash University
Later from Invert Graphite
- Appointment of Dr. Rosalind Wilson as CEO
- Appendix 4C - quarterly
- Appendix 4E and Full Year Statutory Accounts
- Shareholder communication - clinical trial update
- Appendix 4C for the September Quarter
Follow Invert Graphite into a list and get an email when it puts out news.
Follow Invert Graphite